Ongoing monitoring during treatment is built into the care structure, not an afterthought
In the UK, suitability for approved weight management medicines is assessed in line with NICE guidance for example, NICE TA875 for semaglutide (Wegovy) and NICE TA820 for tirzepatide (Mounjaro) in type 2 diabetes which considers BMI thresholds, comorbidities, previous attempts at lifestyle intervention, and overall clinical context
This process is fundamentally different from the skin repair mechanisms that other peptides target, though the downstream consequences of impaired Wnt signaling affect both hair and skin quality
Staying hydrated throughout the day helps manage this symptom
In CD36 knockout mice, Hexarelin's cardioprotective effect is completely abolished, definitively proving its heart benefits depend on this scavenger receptor rather than GH elevation